1 Big Question to Ask Yourself Before Buying Aurora Cannabis

Aurora Cannabis (NYSE: ACB) is an underperforming stock, with its shares down more than 90% over the last 12 months. On the flip side, the company has continually disappointed investors through share dilution and consistent writedowns. There's no doubt that if Aurora turns things around in the next 12 months, grows its sales, and achieves a positive adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA), then the stock could reverse its current downward trajectory.